Summary

The global Cell and Gene Therapy (CGT) Pharmaceuticals market size is predicted to grow from US$ 18030 million in 2025 to US$ 61770 million in 2032; it is expected to grow at a CAGR of 19.6% from 2026 to 2032.

Cell and Gene Therapy (CGT) drugs are a class of innovative treatments that treat diseases by changing the patient's cells or genes. Specifically, CGT drugs usually include: 1. Gene therapy: by introducing, deleting or repairing genes into the patient's cells, the purpose is to correct diseases caused by genetic defects or mutations. For example, gene therapy can deliver normal genes to patients through viral vectors to replace missing or defective genes.

2. Cell therapy: by changing or enhancing the patient's own cells and then re-injecting them into the body for treatment. Common cell therapies include using immune cells (such as CAR-T cells) to treat cancer or using stem cells to repair damaged tissues.

Global key Cell and Gene Therapy (CGT) Pharmaceuticals players cover Vericel, Castle Creek, Terumo, Nipro, BioCardia, etc.

Report Scope
LPI (LP Information)' newest research report, the “Cell and Gene Therapy (CGT) Pharmaceuticals Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy (CGT) Pharmaceuticals sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy (CGT) Pharmaceuticals sales for 2026 through 2032. With Cell and Gene Therapy (CGT) Pharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy (CGT) Pharmaceuticals industry.

This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy (CGT) Pharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy (CGT) Pharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy (CGT) Pharmaceuticals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy (CGT) Pharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy (CGT) Pharmaceuticals.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy (CGT) Pharmaceuticals market by product type, application, key players and key regions and countries.

Market Segmentation
Segmentation by Type:
Cell Therapy Drugs
Gene Therapy Drugs

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Vericel
Castle Creek
Terumo
Nipro
BioCardia
Sanpower Group
Novartis
Gilead Sciences, Inc./Fosun Kite
BMS
JW (Cayman) Therapeutics
Legend Biotech Corp./Johnson & Johnson
Innovent Biologics, Inc./IASO Biotherapeutics
Juventas/CASI
CARsgen Therapeutics Holdings
Huadong Medicine
inno.N
lovance
Mesoblast
Takeda
Pierre fabre
Aurion Biotech
Gamida Cell
CellTrans
SiBiono Gene Technology
Ferring
Kyowa Kirin
uniQure
Roche
PTC Therapeutics
BioMarin
CSL
Sarepta
AnGes
bluebird bio
Krystal Biotech

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (2021-2032)
2.1.2 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy (CGT) Pharmaceuticals by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy (CGT) Pharmaceuticals Segment by Type
2.2.1 Cell Therapy Drugs
2.2.2 Gene Therapy Drugs
2.2.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type
2.2.3.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy (CGT) Pharmaceuticals Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application
2.3.4.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application (2021-2026)

3 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Player
3.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy (CGT) Pharmaceuticals by Region
4.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth (2021-2026)

5 Americas
5.1 Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast
10.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.1.3 APAC Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.1.4 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.2 Americas Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.2.2 Canada Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.2.3 Mexico Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.2.4 Brazil Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.3 APAC Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast
10.3.2 Japan Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.3.3 Korea Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.3.5 India Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.3.6 Australia Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.4 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.4.2 France Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.4.3 UK Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.4.4 Italy Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.4.5 Russia Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.5 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.5.2 South Africa Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.5.3 Israel Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.5.4 Turkey Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast
10.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy (CGT) Pharmaceuticals Forecast

11 Key Players Analysis
11.1 Vericel
11.1.1 Vericel Company Information
11.1.2 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.1.3 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Vericel Main Business Overview
11.1.5 Vericel Latest Developments
11.2 Castle Creek
11.2.1 Castle Creek Company Information
11.2.2 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.2.3 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Castle Creek Main Business Overview
11.2.5 Castle Creek Latest Developments
11.3 Terumo
11.3.1 Terumo Company Information
11.3.2 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.3.3 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Terumo Main Business Overview
11.3.5 Terumo Latest Developments
11.4 Nipro
11.4.1 Nipro Company Information
11.4.2 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.4.3 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Nipro Main Business Overview
11.4.5 Nipro Latest Developments
11.5 BioCardia
11.5.1 BioCardia Company Information
11.5.2 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.5.3 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 BioCardia Main Business Overview
11.5.5 BioCardia Latest Developments
11.6 Sanpower Group
11.6.1 Sanpower Group Company Information
11.6.2 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.6.3 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sanpower Group Main Business Overview
11.6.5 Sanpower Group Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.7.3 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Gilead Sciences, Inc./Fosun Kite
11.8.1 Gilead Sciences, Inc./Fosun Kite Company Information
11.8.2 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.8.3 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Gilead Sciences, Inc./Fosun Kite Main Business Overview
11.8.5 Gilead Sciences, Inc./Fosun Kite Latest Developments
11.9 BMS
11.9.1 BMS Company Information
11.9.2 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.9.3 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BMS Main Business Overview
11.9.5 BMS Latest Developments
11.10 JW (Cayman) Therapeutics
11.10.1 JW (Cayman) Therapeutics Company Information
11.10.2 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.10.3 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 JW (Cayman) Therapeutics Main Business Overview
11.10.5 JW (Cayman) Therapeutics Latest Developments
11.11 Legend Biotech Corp./Johnson & Johnson
11.11.1 Legend Biotech Corp./Johnson & Johnson Company Information
11.11.2 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.11.3 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Legend Biotech Corp./Johnson & Johnson Main Business Overview
11.11.5 Legend Biotech Corp./Johnson & Johnson Latest Developments
11.12 Innovent Biologics, Inc./IASO Biotherapeutics
11.12.1 Innovent Biologics, Inc./IASO Biotherapeutics Company Information
11.12.2 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.12.3 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Innovent Biologics, Inc./IASO Biotherapeutics Main Business Overview
11.12.5 Innovent Biologics, Inc./IASO Biotherapeutics Latest Developments
11.13 Juventas/CASI
11.13.1 Juventas/CASI Company Information
11.13.2 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.13.3 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Juventas/CASI Main Business Overview
11.13.5 Juventas/CASI Latest Developments
11.14 CARsgen Therapeutics Holdings
11.14.1 CARsgen Therapeutics Holdings Company Information
11.14.2 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.14.3 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 CARsgen Therapeutics Holdings Main Business Overview
11.14.5 CARsgen Therapeutics Holdings Latest Developments
11.15 Huadong Medicine
11.15.1 Huadong Medicine Company Information
11.15.2 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.15.3 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Huadong Medicine Main Business Overview
11.15.5 Huadong Medicine Latest Developments
11.16 inno.N
11.16.1 inno.N Company Information
11.16.2 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.16.3 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 inno.N Main Business Overview
11.16.5 inno.N Latest Developments
11.17 lovance
11.17.1 lovance Company Information
11.17.2 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.17.3 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 lovance Main Business Overview
11.17.5 lovance Latest Developments
11.18 Mesoblast
11.18.1 Mesoblast Company Information
11.18.2 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.18.3 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Mesoblast Main Business Overview
11.18.5 Mesoblast Latest Developments
11.19 Takeda
11.19.1 Takeda Company Information
11.19.2 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.19.3 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Takeda Main Business Overview
11.19.5 Takeda Latest Developments
11.20 Pierre fabre
11.20.1 Pierre fabre Company Information
11.20.2 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.20.3 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Pierre fabre Main Business Overview
11.20.5 Pierre fabre Latest Developments
11.21 Aurion Biotech
11.21.1 Aurion Biotech Company Information
11.21.2 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.21.3 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Aurion Biotech Main Business Overview
11.21.5 Aurion Biotech Latest Developments
11.22 Gamida Cell
11.22.1 Gamida Cell Company Information
11.22.2 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.22.3 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Gamida Cell Main Business Overview
11.22.5 Gamida Cell Latest Developments
11.23 CellTrans
11.23.1 CellTrans Company Information
11.23.2 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.23.3 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 CellTrans Main Business Overview
11.23.5 CellTrans Latest Developments
11.24 SiBiono Gene Technology
11.24.1 SiBiono Gene Technology Company Information
11.24.2 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.24.3 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 SiBiono Gene Technology Main Business Overview
11.24.5 SiBiono Gene Technology Latest Developments
11.25 Ferring
11.25.1 Ferring Company Information
11.25.2 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.25.3 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Ferring Main Business Overview
11.25.5 Ferring Latest Developments
11.26 Kyowa Kirin
11.26.1 Kyowa Kirin Company Information
11.26.2 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.26.3 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Kyowa Kirin Main Business Overview
11.26.5 Kyowa Kirin Latest Developments
11.27 uniQure
11.27.1 uniQure Company Information
11.27.2 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.27.3 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 uniQure Main Business Overview
11.27.5 uniQure Latest Developments
11.28 Roche
11.28.1 Roche Company Information
11.28.2 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.28.3 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 Roche Main Business Overview
11.28.5 Roche Latest Developments
11.29 PTC Therapeutics
11.29.1 PTC Therapeutics Company Information
11.29.2 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.29.3 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 PTC Therapeutics Main Business Overview
11.29.5 PTC Therapeutics Latest Developments
11.30 BioMarin
11.30.1 BioMarin Company Information
11.30.2 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.30.3 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 BioMarin Main Business Overview
11.30.5 BioMarin Latest Developments
11.31 CSL
11.31.1 CSL Company Information
11.31.2 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.31.3 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 CSL Main Business Overview
11.31.5 CSL Latest Developments
11.32 Sarepta
11.32.1 Sarepta Company Information
11.32.2 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.32.3 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 Sarepta Main Business Overview
11.32.5 Sarepta Latest Developments
11.33 AnGes
11.33.1 AnGes Company Information
11.33.2 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.33.3 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 AnGes Main Business Overview
11.33.5 AnGes Latest Developments
11.34 bluebird bio
11.34.1 bluebird bio Company Information
11.34.2 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.34.3 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 bluebird bio Main Business Overview
11.34.5 bluebird bio Latest Developments
11.35 Krystal Biotech
11.35.1 Krystal Biotech Company Information
11.35.2 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
11.35.3 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 Krystal Biotech Main Business Overview
11.35.5 Krystal Biotech Latest Developments

12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy (CGT) Pharmaceuticals Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cell Therapy Drugs
Table 4. Major Players of Gene Therapy Drugs
Table 5. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type (2021-2026)
Table 8. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application (2021-2026)
Table 11. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Player (2021-2026)
Table 13. Cell and Gene Therapy (CGT) Pharmaceuticals Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy (CGT) Pharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Region (2021-2026)
Table 19. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Country (2021-2026)
Table 23. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type (2021-2026)
Table 25. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application (2021-2026)
Table 27. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Region (2021-2026)
Table 29. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Country (2021-2026)
Table 33. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy (CGT) Pharmaceuticals
Table 39. Key Market Challenges & Risks of Cell and Gene Therapy (CGT) Pharmaceuticals
Table 40. Key Industry Trends of Cell and Gene Therapy (CGT) Pharmaceuticals
Table 41. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Vericel Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 46. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 47. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Vericel Main Business
Table 49. Vericel Latest Developments
Table 50. Castle Creek Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 51. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 52. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Castle Creek Main Business
Table 54. Castle Creek Latest Developments
Table 55. Terumo Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 56. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 57. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Terumo Main Business
Table 59. Terumo Latest Developments
Table 60. Nipro Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 61. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 62. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Nipro Main Business
Table 64. Nipro Latest Developments
Table 65. BioCardia Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 66. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 67. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. BioCardia Main Business
Table 69. BioCardia Latest Developments
Table 70. Sanpower Group Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 71. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 72. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Sanpower Group Main Business
Table 74. Sanpower Group Latest Developments
Table 75. Novartis Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 76. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 77. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments
Table 80. Gilead Sciences, Inc./Fosun Kite Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 81. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 82. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Gilead Sciences, Inc./Fosun Kite Main Business
Table 84. Gilead Sciences, Inc./Fosun Kite Latest Developments
Table 85. BMS Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 86. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 87. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. BMS Main Business
Table 89. BMS Latest Developments
Table 90. JW (Cayman) Therapeutics Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 91. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 92. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. JW (Cayman) Therapeutics Main Business
Table 94. JW (Cayman) Therapeutics Latest Developments
Table 95. Legend Biotech Corp./Johnson & Johnson Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 96. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 97. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Legend Biotech Corp./Johnson & Johnson Main Business
Table 99. Legend Biotech Corp./Johnson & Johnson Latest Developments
Table 100. Innovent Biologics, Inc./IASO Biotherapeutics Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 101. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 102. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Innovent Biologics, Inc./IASO Biotherapeutics Main Business
Table 104. Innovent Biologics, Inc./IASO Biotherapeutics Latest Developments
Table 105. Juventas/CASI Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 106. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 107. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Juventas/CASI Main Business
Table 109. Juventas/CASI Latest Developments
Table 110. CARsgen Therapeutics Holdings Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 111. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 112. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. CARsgen Therapeutics Holdings Main Business
Table 114. CARsgen Therapeutics Holdings Latest Developments
Table 115. Huadong Medicine Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 116. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 117. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Huadong Medicine Main Business
Table 119. Huadong Medicine Latest Developments
Table 120. inno.N Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 121. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 122. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. inno.N Main Business
Table 124. inno.N Latest Developments
Table 125. lovance Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 126. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 127. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. lovance Main Business
Table 129. lovance Latest Developments
Table 130. Mesoblast Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 131. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 132. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Mesoblast Main Business
Table 134. Mesoblast Latest Developments
Table 135. Takeda Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 136. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 137. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Takeda Main Business
Table 139. Takeda Latest Developments
Table 140. Pierre fabre Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 141. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 142. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Pierre fabre Main Business
Table 144. Pierre fabre Latest Developments
Table 145. Aurion Biotech Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 146. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 147. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Aurion Biotech Main Business
Table 149. Aurion Biotech Latest Developments
Table 150. Gamida Cell Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 151. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 152. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Gamida Cell Main Business
Table 154. Gamida Cell Latest Developments
Table 155. CellTrans Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 156. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 157. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. CellTrans Main Business
Table 159. CellTrans Latest Developments
Table 160. SiBiono Gene Technology Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 161. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 162. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. SiBiono Gene Technology Main Business
Table 164. SiBiono Gene Technology Latest Developments
Table 165. Ferring Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 166. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 167. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 168. Ferring Main Business
Table 169. Ferring Latest Developments
Table 170. Kyowa Kirin Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 171. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 172. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 173. Kyowa Kirin Main Business
Table 174. Kyowa Kirin Latest Developments
Table 175. uniQure Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 176. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 177. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 178. uniQure Main Business
Table 179. uniQure Latest Developments
Table 180. Roche Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 181. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 182. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 183. Roche Main Business
Table 184. Roche Latest Developments
Table 185. PTC Therapeutics Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 186. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 187. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 188. PTC Therapeutics Main Business
Table 189. PTC Therapeutics Latest Developments
Table 190. BioMarin Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 191. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 192. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 193. BioMarin Main Business
Table 194. BioMarin Latest Developments
Table 195. CSL Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 196. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 197. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 198. CSL Main Business
Table 199. CSL Latest Developments
Table 200. Sarepta Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 201. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 202. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 203. Sarepta Main Business
Table 204. Sarepta Latest Developments
Table 205. AnGes Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 206. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 207. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 208. AnGes Main Business
Table 209. AnGes Latest Developments
Table 210. bluebird bio Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 211. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 212. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 213. bluebird bio Main Business
Table 214. bluebird bio Latest Developments
Table 215. Krystal Biotech Details, Company Type, Cell and Gene Therapy (CGT) Pharmaceuticals Area Served and Its Competitors
Table 216. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product Offered
Table 217. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 218. Krystal Biotech Main Business
Table 219. Krystal Biotech Latest Developments

List of Figures
Figure 1. Cell and Gene Therapy (CGT) Pharmaceuticals Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy (CGT) Pharmaceuticals Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy (CGT) Pharmaceuticals Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type in 2025
Figure 10. Cell and Gene Therapy (CGT) Pharmaceuticals in Hospital
Figure 11. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market: Hospital (2021-2026) & ($ millions)
Figure 12. Cell and Gene Therapy (CGT) Pharmaceuticals in Clinic
Figure 13. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market: Clinic (2021-2026) & ($ millions)
Figure 14. Cell and Gene Therapy (CGT) Pharmaceuticals in Other
Figure 15. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market: Other (2021-2026) & ($ millions)
Figure 16. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application in 2025
Figure 17. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Player in 2025
Figure 18. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Region (2021-2026)
Figure 19. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2021-2026 ($ millions)
Figure 20. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2021-2026 ($ millions)
Figure 21. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2021-2026 ($ millions)
Figure 23. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Value Market Share by Country in 2025
Figure 24. United States Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Region in 2025
Figure 29. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 30. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 31. China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 35. India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Country in 2025
Figure 38. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 39. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 40. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 41. France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 54. APAC Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 55. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 57. United States Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 58. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 59. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 60. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 61. China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 62. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 63. Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 65. India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 66. Australia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 67. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 68. France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 69. UK Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 70. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 71. Russia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 72. Egypt Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 73. South Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 74. Israel Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 75. Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)
Figure 76. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Cell and Gene Therapy (CGT) Pharmaceuticals Market Size 2027-2032 ($ millions)